Molecular mapping in the CNS

Current Pharmaceutical Design

Volumn 8, Issue 17, 2002, Pages 1547-1570

  Wong, Margaret G ^a   Tehan, Benjamin G ^a   Lloyd, Edward J ^a  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 CHLOROPHENYL) 5H PYRAZOLO[4,3 C]QUINOLIN 3 ONE; 2,3 QUINOXALINEDIONE DERIVATIVE; 3 AMINO 2 (3 CARBOXYPROPYL) 6 (4 METHOXYPHENYL)PYRIDAZINIUM BROMIDE; 3 HYDROXY 5 (4 PIPERIDYL)ISOXAZOLE; 4 AMINO 2 THIABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID C RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; BACLOFEN; BENZODIAZEPINE RECEPTOR; BICUCULLINE; DIAZEPAM; DOPAMINE RECEPTOR; EGLUMETAD; G PROTEIN COUPLED RECEPTOR; GLUTAMATE RECEPTOR; IONOTROPIC RECEPTOR; LIGAND; METABOTROPIC RECEPTOR; MUSCIMOL; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; OPIATE RECEPTOR; PICROTOXININ; QUISQUALIC ACID; TIAGABINE; UNINDEXED DRUG; VIGABATRIN; ZOLPIDEM; CENTRAL NERVOUS SYSTEM AGENTS;

CENTRAL NERVOUS SYSTEM; COMPUTER SYSTEM; CONTROLLED STUDY; DRUG DESIGN; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG RESEARCH; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; HUMAN; METHODOLOGY; MOLECULAR INTERACTION; MOLECULAR MODEL; NONHUMAN; PHARMACOPHORE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN STRUCTURE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; THREE DIMENSIONAL IMAGING; CHEMICAL STRUCTURE; CHEMISTRY; COMBINATORIAL CHEMISTRY;

CENTRAL NERVOUS SYSTEM AGENTS; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG DESIGN; HUMAN; MODELS, MOLECULAR; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; HUMANS;

EID: 0036019173     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612023394250     Document Type: Review

References (205)

1. Applied therapeutics: The clinical use of drugs